Part 8: Fluid Therapy in Medical Disorders

40: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State

 

Chapter outlines

DIABETIC KETOACIDOSIS
Definition
Pathophysiology
Treatment
Fluid replacement
- Basic principles
- Rate of fluid replacement
- Selecting right fluid for replacement
Insulin therapy
Potassium supplementation
Treatment of metabolic acidosis
Correction of hypophosphatemia
Identify and Treat Precipitating Factors
Avoidance of Therapy Related Complications
Monitoring of Treatment
HYPEROSMOLAR HYPERGLYCEMIC STATE
Presentation
Diagnosis
Treatment
Fluid therapy
Insulin treatment
Electrolyte management
Supportive treatment
Monitoring
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are serious and potentially life-threatening metabolic complications of diabetes mellitus (DM). While DKA is a common hyperglycemic emergency with a low mortality rate, characterized by hyperglycemia and ketoacidosis, HHS, on the other hand, is less common, characterized by hyperglycemia and hyperosmolality without ketoacidosis, but has a high mortality rate.

DIABETIC KETOACIDOSIS

Diabetic ketoacidosis is a medical emergency that can be life-threatening if not treated promptly. DKA is one of the common complications of type-I diabetes mellitus (IDDM) associated with significant fluid and electrolyte imbalance.

DEFINITION

Diabetic ketoacidosis is characterized by the triad of [1, 2]:
  1. Hyperglycemia: Blood glucose concentration of >200 mg/dL or 11.0 mmol/L.
  2. Metabolic acidosis: Venous pH <7.3 and serum bicarbonate <18 mmol/L [1] (or 15 mmol/L [2]).
  3. Ketonemia or ketonuria: Capillary ketones >3 mmol/L or urine ketones ++ (“moderate or large”).
If a facility to measure blood beta-hydroxybutyrate (BOHB) concentration is available, it is a more precise and sensitive test to diagnose DKA [3].

REFERENCES

  1. Glaser N, Fritsch M, Priyambada L, et al: ISPAD Clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835–56.
  2. JBDS. JBDS-IP Joint British Diabetes Societies Inpatient Care Group. The Management of Diabetic Ketoacidosis in Adults, March 2023 Update: JBDS Guidelines [Internet]. London: ABCD; 2023 Mar. Available from: https://abcd.care/sites/abcd.care/files/site_uploads/JBDS_Guidelines_Current/JBDS_02_DKA_Guideline_with_QR_code_March_2023.pdf.
  3. Tremblay ES, Millington K, Monuteaux MC, et al. Plasma β-Hydroxybutyrate for the Diagnosis of Diabetic Ketoacidosis in the Emergency Department. Pediatr Emerg Care. 2021;37(12):e1345–e1350.
  4. Dhatariya K. Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis. Rev Diabet Stud. 2016;13(4):217–225.
  5. Rawla P, Vellipuram AR, Bandaru SS, et al. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep. 2017;2017:17–0081.
  6. Nasa P, Chaudhary S, Shrivastava PK, et al. Euglycemic diabetic ketoacidosis: A missed diagnosis. World J Diabetes. 2021;12(5):514–523.
  7. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343.
  8. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(12):2739–48.
  9. English P, Williams G. Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J. 2004;80(943):253–261.
  10. DeFronzo RA, Hompesch M, Kasichayanula SK, et al. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes. Diabetes Care 2013;36(10):3169–3176.
  11. Arora S, Cheng D, Wyler B, et al. Prevalence of hypokalemia in ED patients with diabetic ketoacidosis. Am J Emerg Med 2012;30(3):481–4.
  12. Adrogué HJ, Lederer ED, Suki WN, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986;65(3):163–172.
  13. Conte G, Dal Canton A, Imperatore P, et al. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int. 1990;38(2):301–7.
  14. Umpierrez GE, Murphy MB, Kitabchi AE. Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome. Diabetes Spectrum 2002;15(1):28–36.
  15. Dhatariya KK, Nunney I, Higgins K, et al. A national survey of the management of diabetic ketoacidosis in the UK in 2014. Diabet Med. 2016;33(2):252–260.
  16. Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021;9(3):174–188.
  17. Mein SA, Schwartzstein RM, Richards JB. Sugar, Sodium, and Water: A Recipe for Disaster. Ann Am Thorac Soc. 2020;17(8):1016–1020.
  18. van der Vaart A, Waanders F, van Beek AP, et al. Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study. BMJ Open Diabetes Res Care. 2021;9(1):e002018.
  19. Choi HS, Kwon A, Chae HW, et al. Respiratory failure in a diabetic ketoacidosis patient with severe hypophosphatemia. Ann Pediatr Endocrinol Metab. 2018;23(2):103–106.
  20. Kuppermann N, Ghetti S, Schunk JE, et al. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. New England Journal of Medicine 2018;378(24):2275–2287.
  21. University Hospitals of Leicester. Management of Diabetic Ketoacidosis (DKA) in Adults Guideline (V4 approved by Policy and Guideline Committee on 27 February 2023 Trust ref: B66/2011) [Guidelines]. NHS; 2023. Available from: https://secure.library.leicestershospitals.nhs.uk/PAGL/Shared%20Documents/Diabetic%20Ketoacidosis%20(DKA)%20in%20Adults%20UHL%20Guideline.pdf.
  22. Fluid and insulin therapy in children and young people with diabetic ketoacidosis: An update to the NICE NG18 guideline. Journal of Diabetes Nursing 2021;25:JDN171. Available from: https://www.nice.org.uk/guidance/ng18/chapter/Recommendations#fluid-and-insulin-therapy.
  23. Diabetes (type 1 and type 2) in children and young people: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2022 Jun 29. (NICE Guideline, No. 18.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK555102/.
  24. South Australia (SA) Health. Clinical practice guideline on diabetic ketoacidosis (DKA) in children. Adelaide: SA Health; 2019. Available from: https://www.sahealth.sa.gov.au/wps/wcm/connect/04ac0b8040d0430e975ebf40b897efc8/Diabetic+Ketoacidosis+%28DKA%29+in+Children+and+Adolescents_Paed_v2_1.pdf?MOD=AJPERES&amp;CACHEID=ROOTWORKSPACE-04ac0b8040d0430e975ebf40b897efc8-obYYWor.
  25. Diabetes Canada Clinical Practice Guidelines Expert Committee; Goguen J, Gilbert J. Hyperglycemic Emergencies in Adults. Can J Diabetes. 2018;42(1):S109–S114.
  26. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243–51.
  27. Oliver WD, Willis GC, Hines MC, et al. Comparison of PlasmaLyte A and sodium chloride 0.9% for fluid resuscitation of patients with diabetic ketoacidosis. Hosp Pharm 2018;53(5):326–330.
  28. Yung M, Letton G, Keeley S. Controlled trial of Hartmann’s solution versus 0.9% saline for diabetic ketoacidosis. J Paediatr Child Health. 2017;53(1):12–17.
  29. Mahler S, Conrad S, Wang H, et al. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med. 2011;29(6):670–674.
  30. Ramanan M, Attokaran A, Murray L. SCOPE-DKA Collaborators and Queensland Critical Care Research Network (QCCRN). Sodium chloride or PlasmaLyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial. Intensive Care Med. 2021;47(11):1248–1257.
  31. Self W, Evans C, Jenkins C, et al. Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis. JAMA Netw Open. 2020;3:(11):e2024596.
  32. Van Zyl D, Rheeder P, Delport E. Fluid management in diabetic-acidosis Ringer’s lactate versus normal saline: a randomized controlled trial. QJM. 2012;105(4):337–343.
  33. Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis – a systematic review. Ann Intensive Care 2011;1(1):23.
  34. Bergmann KR, Abuzzahab MJ, Nowak J, et al. Resuscitation with Ringer’s lactate compared with normal saline for pediatric diabetic ketoacidosis. Pediatr Emerg Care 2021;37(5):e236–e242.
  35. Jahangir A, Jahangir A, Siddiqui FS, et al. Normal Saline Versus Low Chloride Solutions in Treatment of Diabetic Ketoacidosis: A Systematic Review of Clinical Trials. Cureus. 2022;14(1):e21324.
  36. Catahay JA, Polintan ET, Casimiro M, et al. Balanced electrolyte solutions versus isotonic saline in adult patients with diabetic ketoacidosis: A systematic review and meta-analysis. Heart Lung. 2022;54:74–79.
  37. Alghamdi NA, Major P, Chaudhuri D, et al. Saline Compared to Balanced Crystalloid in Patients With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Explor. 2022;4(1):e0613.
  38. Zardoost P, Khan Z, Wehrum HL, et al. Hypernatremia in Diabetic Ketoacidosis: A Rare Metabolic Derangement Requiring a Cautionary Approach in Fluid Resuscitation. Cureus 2023;15(3):e36689.
  39. Dressler DD. Normal Saline vs. Balanced Crystalloid for Diabetic Ketoacidosis. NEJM JOURNAL Watch. 2022 Jul 26. Visit: https://www.jwatch.org/na55108/2022/07/26/normal-saline-vs-balanced-crystalloid-diabetic.
  40. Aldhaeefi M, Aldardeer NF, Alkhani N, et al. Updates in the Management of Hyperglycemic Crisis. Front Clin Diabetes Healthc. 2022;2:820728.
  41. Effects of Balanced Crystalloids vs. Saline in Adults with Diabetic Ketoacidosis [Internet]. Anaesthesia News. 2021. Available from: https://anaesthesianews.wordpress.com/2021/12/12/effects-of-balanced-crystalloids-vs-saline-in-adults-with-diabetic-ketoacidosis/.
  42. Farkas J. Diabetic Ketoacidosis (DKA). emcrit.org. 2021. Available from: https://emcrit.org/ibcc/dka/.
  43. Gripp K, Trottier ED, Thakore S, et al. Current recommendations for management of paediatric diabetic ketoacidosis. Canadian Paediatric Society 2022.
  44. BSPED Guideline for the Management of Children and Young People under the age of 18 years with Diabetic Ketoacidosis - 2021 [Internet]. British Society for Paediatric Endocrinology and Diabetes; 2021. Available from: https://www.bsped.org.uk/clinical-resources/bsped-dka-guidelines/.
  45. Forestell B, Battaglia F, Sharif S, et al. Insulin Infusion Dosing in Pediatric Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Explor. 2023;5(2):e0857.
  46. Kilpatrick ES, Butler AE, Ostlundh L, et al. Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis. Diabetes Care. 2022;45(2):267–272.
  47. Ma OJ, Rush MD, Godfrey MM, et al. Arterial blood gas results rarely influence emergency physician management of patients with suspected diabetic ketoacidosis. Acad Emerg Med. 2003;10(8):836–41.
  48. Menchine M, Probst MA, Agy C, et al. Diagnostic accuracy of venous blood gas electrolytes for identifying diabetic ketoacidosis in the emergency department. Acad Emerg Med. 2011;18(10):1105–1108.
  49. Byrne AL, Bennett M, Chatterji R, et al. Peripheral venous and arterial blood gas analysis in adults: are they comparable? A systematic review and meta-analysis. Respirology. 2014;19(2):168–175.
  50. Prasad H, Vempalli N, Agrawal N, et al. Correlation and agreement between arterial and venous blood gas analysis in patients with hypotension-an emergency department-based cross-sectional study. Int J Emerg Med. 2023;16(1):18.
  51. Milanesi A, Weinreb JE. Hyperglycemic Hyperosmolar State. [Updated 2018 Aug 1]. In: Feingold KR, Anawalt B, Blackman MR, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278976/.
  52. Mustafa OG, Haq M, Dashora U, et al. Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Diabet Med. 2023;40(3):e15005.
  53. Zeitler P, Haqq A, Rosenbloom A, et al. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. Rev J Pediatr. 2011;158(1):9–14.
TABLE OF CONTENTS